AskDoctor
☰
← Back to Kansas City Doctors
Photo of JEFFREY M HOLZBEIERLEIN, CONDITIONS TREATED:Testicular, Bladder and Kidney Cancer, Female Urology and Incontinence, Interstitial Cystitis, Kidney Stones, Male Infertility, Vasectomy, Prostate Enlargement (BPH), Sexual Dysfunction, Urethra Structures, Vasectomy Reversal, Overactive Urinary Bladder, Prostatitis, Urologic Emergencies and Erectile DysfunctionTREATMENTS OFFERED:Nephrectomy, Cystoscopy, Urinary Flow Tests, Cystourethroscopy & Kidney Transplant in KANSAS CITY
β˜… 4.3 (112 reviews)

JEFFREY M HOLZBEIERLEIN MD

CONDITIONS TREATED:Testicular, Bladder and Kidney Cancer, Female Urology and Incontinence, Interstitial Cystitis, Kidney Stones, Male Infertility, Vasectomy, Prostate Enlargement (BPH), Sexual Dysfunction, Urethra Structures, Vasectomy Reversal, Overactive Urinary Bladder, Prostatitis, Urologic Emergencies and Erectile DysfunctionTREATMENTS OFFERED:Nephrectomy, Cystoscopy, Urinary Flow Tests, Cystourethroscopy & Kidney Transplant in Kansas City

Clinic: THE UNIVERSITY OF KANSAS HOSPITAL

Address: πŸ—ΊοΈ 4000 Cambridge Street, Kansas City, KS 66160

Phone: +1-913-588-1227

Email: jho***@k***.edu

Website: Visit Website

Insurance Accepted: Aetna, American Enterprise Group, Anthem, Anthem Blue Cross Blue Shield, Assurant Health, Blue Cross Blue Shield, CareFirst Blue Cross Blue Shield, Cigna, Commercial Insurance Company, CoreSource, Coventry Health Care, First Health, Government Employees Health Association (GEHA), HAP Insurance, Homestate Health Plan, Humana, Mail Handlers Benefit Plan (MHBP), MultiPlan, National Elevator, PHP-Physicians Health Plan & UnitedHealthCare

Experience: Since 1994

Available Timing

Working hours not explicitly listed. Please call the clinic for availability.

About JEFFREY M HOLZBEIERLEIN

Meet Dr. Jeffrey M Holzbeierlein, a board-certified urology specialist with expertise in genitourinary malignancies such as kidney, testicular, bladder, and penile cancers. He obtained his medical degree from The University of Oklahoma College of Medicine, completed his residency at Vanderbilt University Medical Center, and underwent further training at Memorial Sloan Kettering Cancer Center. Dr. Holzbeierlein's research focuses on Hsp90 inhibitors in bladder cancer and improving outcomes following cystectomy. He is a respected professional who reviews submissions for prestigious journals like the Journal of Urology, Cancer, and Urologic Oncology. With numerous peer-reviewed journal articles, presentations, and abstracts in urologic oncology publications, he has contributed significantly to the field. Dr. Holzbeierlein also serves on the oral board committee for the American Board of Urology and offers his expertise in Westwood.